Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Johnson and Johnson
McKesson
Merck

Last Updated: October 6, 2022

Finafloxacin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for finafloxacin and what is the scope of freedom to operate?

Finafloxacin is the generic ingredient in one branded drug marketed by Merlion Pharms Gmbh and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Finafloxacin has forty-two patent family members in eighteen countries.

Summary for finafloxacin
International Patents:42
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 36
Clinical Trials: 7
Patent Applications: 236
DailyMed Link:finafloxacin at DailyMed
Recent Clinical Trials for finafloxacin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MerLion Pharmaceuticals GmbHPhase 2
MerLion Pharmaceuticals GmbHPhase 1

See all finafloxacin clinical trials

US Patents and Regulatory Information for finafloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for finafloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 See Plans and Pricing See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for finafloxacin

Country Patent Number Title Estimated Expiration
South Korea 101541823 See Plans and Pricing
Japan 5784012 See Plans and Pricing
South Korea 20120114211 COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS See Plans and Pricing
Mexico 2012000136 COMPOSICIONES QUE COMPRENDEN FINAFLOXACINA Y METODOS PARA TRATAR INFECCIONES OFTALMICAS, OTICAS, O NASALES. (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS.) See Plans and Pricing
South Korea 20150090045 피나플록사신 현탁 조성물 (FINAFLOXACIN SUSPENSION COMPOSITIONS) See Plans and Pricing
South Africa 201109492 COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC,OTIC,OR NASAL INFECTIONS See Plans and Pricing
Russian Federation 2012103458 КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ФИНАФЛОКСАЦИИ, И СПОСОБЫ ЛЕЧЕНИЯ ОФТАЛЬМОЛОГИЧЕСКИХ, УШНЫХ ИЛИ НАЗАЛЬНЫХ ИНФЕКЦИЙ See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
McKinsey
Harvard Business School
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.